Brca2-related Breast Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-11-06
Clinical Trial Update: A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study) [Phase 2]
Phase 2 ABRAZO study of talazoparib in locally advanced/metastatic breast cancer with BRCA mutations terminated; results posted in 2017.